Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer

Tumor microenvironment comprises of a variety of cell types, which is quite complex and involved in chemotherapy and immune checkpoint blockage resistance. In order to explore the mechanisms involved in tumor immune microenvironment in pancreatic ductal adenocarcinoma (PDAC), we first constructed an...

Full description

Bibliographic Details
Main Authors: Hao Qian, Hongzhe Li, Junjie Xie, Xiongxiong Lu, Fanlu Li, Weishen Wang, Xiaomei Tang, Minmin Shi, Linxi Jiang, Hongwei Li, Hao Chen, Chenghong Peng, Zhiwei Xu, Xiaxing Deng, Baiyong Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
gene signature
immunity
pancreatic cancer
pancreatic ductal adenocarcinoma
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.682261/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.682261/full

Similar Items